{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:41:30Z","timestamp":1765960890257,"version":"3.41.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.051","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T05:32:38Z","timestamp":1454823158000},"page":"1363-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Ekaterina","family":"Moroz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy A.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Aden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Bordwine","family":"Beeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianda","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Edlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8296-0376","authenticated-orcid":false,"given":"Mirella","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.01.051_bib0210","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.2105\/AJPH.2008.158170","article-title":"Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis","volume":"99","author":"Heffelfinger","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4615-5347-2_9","article-title":"Morphine alters the immune response to influenza virus infection in Lewis rats","volume":"437","author":"Coussons-Read","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0220","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0024-3205(99)00348-3","article-title":"Morphine reduces pulmonary inflammation in response to influenza infection","volume":"65","author":"Coussons-Read","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0225","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","article-title":"Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case\u2013control study","volume":"59","author":"Dublin","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation, and drugs of abuse","volume":"16","author":"Friedman","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/acta.0.1140509","article-title":"Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone","volume":"114","author":"Allolio","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0192-0561(97)00017-9","article-title":"Effects of morphine on purified human blood monocytes. Modifications of properties involved in antiviral defences","volume":"19","author":"Stoll-Keller","year":"1997","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0250","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/15287397709529458","article-title":"Duration of interferon inhibition following single and multiple injections of morphine","volume":"2","author":"Geber","year":"1977","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.04.026","article-title":"Morphine suppresses intracellular interferon-alpha expression in neuronal cells","volume":"199","author":"Wan","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0260","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V95.6.2031","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB\/cJ mice","volume":"95","author":"Sacerdote","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cimid.2006.10.002","article-title":"DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge","volume":"30","author":"Jamali","year":"2007","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0275","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","article-title":"Morphine withdrawal enhances hepatitis C virus replicon expression","volume":"167","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(97)00224-5","article-title":"Opiates as potential cofactors in progression of HIV-1 infections to AIDS","volume":"83","author":"Donahoe","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.01.051_bib0285","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat Med"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0290","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.125.6.2539","article-title":"Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes","volume":"125","author":"McDonough","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0295","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0192-0561(85)90049-9","article-title":"Morphine and methadone impact on human phagocytic physiology","volume":"7","author":"Tubaro","year":"1985","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0300","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)22252-2","article-title":"Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients","volume":"250","author":"Novick","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0305","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0310","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0034-7094(12)70169-1","article-title":"Opioids and the immune system: clinical relevance","volume":"62","author":"Garcia","year":"2012","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0315","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: a systematic review","volume":"7","author":"Baral","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0264-410X(96)00057-6","article-title":"Immunogenicity of influenza vaccine (1993\u201394 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users","volume":"15","author":"Iorio","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0325","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0264-410X(92)90516-M","article-title":"Immune response to hepatitis B vaccine in parenteral drug abusers","volume":"10","author":"Rodrigo","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0330","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archinte.1991.00400030110020","article-title":"Suboptimal response to hepatitis B vaccine in drug users","volume":"151","author":"Rumi","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0335","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2105\/AJPH.93.6.919","article-title":"Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study","volume":"93","author":"Lum","year":"2003","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0340","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1360-0443.2002.00147.x","article-title":"Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response","volume":"97","author":"Quaglio","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0345","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00365540310018833","article-title":"Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: the impact of anti-HBV vaccination","volume":"36","author":"Lugoboni","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0350","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0264-410X(96)00290-3","article-title":"Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users","volume":"15","author":"Lugoboni","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2003.12.001","article-title":"Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users","volume":"74","author":"Quaglio","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0360","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1053\/j.gastro.2009.04.040","article-title":"More rare birds, and the occasional swan","volume":"136","author":"Edlin","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0365","first-page":"107","article-title":"Changes in the precordial electrocardiogram due to the position of the exploring electrode","volume":"44","author":"Burnett","year":"1947","journal-title":"Rocky Mt Med J"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0370","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2008.04.073","article-title":"Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0375","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1128\/JVI.71.6.4347-4355.1997","article-title":"A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro","volume":"71","author":"Mozdzanowska","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0380","first-page":"508","article-title":"WHO phasing of pandemic influenza","volume":"107","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0385","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0264-410X(94)90039-6","article-title":"HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990\u20131992","volume":"12","author":"Pyhala","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(73)93106-1","article-title":"Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity","volume":"2","author":"Hobson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0395","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0400","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF02351503","article-title":"Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community","volume":"76","author":"Lorvick","year":"1999","journal-title":"J Urban Health"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0405","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.vaccine.2016.01.051_bib0410","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00952990.2011.600393","article-title":"Compensation effects on clinical trial data collection in opioid-dependent young adults","volume":"38","author":"Wilcox","year":"2012","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:51:31Z","timestamp":1748771491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001031"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}